{"resourceType":"ValueSet","id":"2.16.840.1.113883.3.464.1003.196.12.1404","meta":{"versionId":"5","lastUpdated":"2018-03-14T01:00:05.000-04:00","profile":["http://hl7.org/fhir/StructureDefinition/shareablevalueset","http://hl7.org/fhir/us/cqfmeasures/StructureDefinition/publishable-valueset-cqfm"]},"extension":[{"url":"http://hl7.org/fhir/StructureDefinition/valueset-author","valueString":"NCQA PHEMUR Author"},{"url":"http://hl7.org/fhir/StructureDefinition/resource-lastReviewDate","valueDate":"2022-12-15"},{"url":"http://hl7.org/fhir/StructureDefinition/valueset-effectiveDate","valueDate":"2018-03-14"}],"url":"http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113883.3.464.1003.196.12.1404","identifier":[{"system":"urn:ietf:rfc:3986","value":"urn:oid:2.16.840.1.113883.3.464.1003.196.12.1404"}],"version":"20180314","name":"ChlophedianolDexchlorpheniraminePse","title":"Chlophedianol / Dexchlorpheniramine / Pse","status":"active","experimental":false,"date":"2018-03-14T01:00:05-04:00","publisher":"NCQA PHEMUR","jurisdiction":[{"coding":[{"system":"urn:iso:std:iso:3166","code":"US"}]}],"purpose":"(Clinical Focus: ),(Data Element Scope: ),(Inclusion Criteria: ),(Exclusion Criteria: )","compose":{"include":[{"valueSet":["http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113883.3.464.1003.196.11.1405"]}]},"expansion":{"identifier":"urn:uuid:f33f0faa-d05c-4e18-bba3-ee6ca413c766","timestamp":"2023-12-11T02:37:00-05:00","total":1,"contains":[{"system":"http://www.nlm.nih.gov/research/umls/rxnorm","version":"11062023","code":"1369971","display":"chlophedianol hydrochloride 6.25 MG/ML / dexchlorpheniramine maleate 0.5 MG/ML / pseudoephedrine hydrochloride 15 MG/ML Oral Solution"}]}}